Notably, among the different tumors, ovarian cancer has the highest incidence of tumor-associated thrombocytosis and the strongest experimental and clinical evidence on the role of inflammation (particularly IL-6) in the development of this paraneoplastic condition [33–35]. Here, IL6 is linked to ovarian carcinoma.